Yasufumi Katanasaka
14PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Nov 21, 2025
Nobiletin Prevents Cardiac Hypertrophy via SIRT5-Mediated Downregulation of p300.Yoichi Sunagawa, Masafumi Funamoto, Toshihide Hamabe-Horiike
|Aug 27, 2025
Correction: Cardiac-specific overexpression of PRMT5 exacerbates pressure overload-induced hypertrophy and heart failure.Yasufumi Katanasaka, Yoichi Sunagawa, Ryoga Sakurai
|Jul 06, 2025
Cardiac-specific overexpression of PRMT5 exacerbates pressure overload-induced hypertrophy and heart failure.Yasufumi Katanasaka, Yoichi Sunagawa, Ryoga Sakurai
|Mar 20, 2024
Fibroblast-specific PRMT5 deficiency suppresses cardiac fibrosis and left ventricular dysfunction in male mice.Yasufumi Katanasaka, Harumi Yabe, Noriyuki Murata
|Feb 24, 2024
Anserine, a Histidine-Containing Dipeptide, Suppresses Pressure Overload-Induced Systolic Dysfunction by Inhibiting Histone Acetyltransferase Activity of p300 in Mice.Yoichi Sunagawa, Ryosuke Tsukabe, Yudai Irokawa
|Jul 11, 2023
6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure.Yuto Kawase, Yoichi Sunagawa, Kana Shimizu
Pageof 3
Frequent Collaborators
9 joint publications
Yoichi Sunagawa
8 joint publications
Kiyoshi Mori
5 joint publications
Satoshi Shimizu
5 joint publications
Maki Komiyama
4 joint publications
Toshihide Hamabe-Horiike
3 joint publications
Tatsuya Morimoto
1 joint publications
Hiromichi Wada
1 joint publications
Yoshiki Arakawa
1 joint publications
Alberto Minassi
1 joint publications
Andreas Koeberle
